| Serial Number | 88693805 |
| Word Mark | METIMEDI |
| Filing Date | Friday, November 15, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 23, 2020 |
| Registration Number | 6084402 |
| Registration Date | Tuesday, June 23, 2020 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 7, 2020 |
| Goods and Services | Anti-cancer preparations; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for immunity adjustment; Vaccines; Pharmaceutical agents for regenerating cells; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemico-pharmaceutical preparations, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Pharmaceuticals for medical purposes for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Antibacterial substances for medical purposes; Antibodies for medical purposes for the treatment of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemical preparations for medical purpose, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic kits for medical diagnostic purposes comprising reagents for use in disease testing, health monitoring and more generally, predictive and preventive medicine in the fields of detecting immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic pharmaceutical preparations for medical purposes; Antibiotics; Tumor suppressing agents; Chemotherapeutics |
| Pseudo Mark | METI MEDI |
| Goods and Services | Research and development of vaccines and medicines; Crude medicines research; Medical and scientific research on adult diseases; Medical and scientific research on cancer; Pharmaceutical products development; Research on the subject of pharmaceuticals; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research for medical products; Medical research; Chemistry services, namely, chemistry consultation, research in the field of chemistry, laboratory research and analysis in the field of chemistry; Chemical research and analysis; Research and development of medical products for others |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 21, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 21, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MetiMedi Pharmaceuticals Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Incheon 22006 KR |
| Party Name | MetiMedi Pharmaceuticals Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Incheon 22006 KR |
| Party Name | MetiMedi Pharmaceuticals Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Incheon 22006 KR |
| Event Date | Event Description |
| Thursday, March 17, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, March 17, 2022 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Thursday, March 17, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, March 17, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, March 17, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, June 23, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, April 15, 2020 | WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST |
| Monday, April 13, 2020 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, April 7, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 7, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 18, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, March 4, 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, March 4, 2020 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Monday, March 2, 2020 | ASSIGNED TO LIE |
| Tuesday, February 25, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, February 25, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, February 25, 2020 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, February 25, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, February 25, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, February 25, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, February 25, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, February 24, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, February 24, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, February 24, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, February 24, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Monday, February 24, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, February 20, 2020 | ASSIGNED TO EXAMINER |
| Thursday, November 21, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, November 19, 2019 | NEW APPLICATION ENTERED IN TRAM |